Lilly’s sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
Finance
Lilly’s revenue soars 48%, driven by demand for its GLP-1s
Lilly’s sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
Anchor News
- 1 min read
Related
More FinanceFinanceOriginal
U.S. economy keeps up the momentum, but rising costs put a cap on new hiring
Anchor News-
FinanceOriginal
I got two email invitations from friends. Is this a phishing scam — or am I suddenly popular?
Anchor News-